Treatment delays in children and young adults with lymphoma: a report from an East Africa lymphoma cohort study
Blood Adv
.
2023 Sep 12;7(17):4962-4965.
doi: 10.1182/bloodadvances.2022009398.
Authors
William Frank Mawalla
1
,
Liz Morrell
2
,
Lulu Chirande
1
,
Caroline Achola
3
,
Hadija Mwamtemi
4
,
Godlove Sandi
4
,
Salama Mahawi
4
,
Atukuzwe Kahakwa
5
,
Paul Ntemi
6
,
Nabalende Hadija
3
,
Elifuraha Mkwizu
5
,
Clara Chamba
1
,
Dimitris Vavoulis
7
,
Anna Schuh
1
7
Affiliations
1
AI-REAL Study, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
2
Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
3
AI-REAL Study, St Mary's Hospital Lacor, Gulu & African Field Epidemiology, Gulu-Uganda, Northern Region, Uganda.
4
AI-REAL Study, Muhimbili National Hospital, Dar es Salaam, Tanzania.
5
AI-REAL Study, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
6
AI-REAL Study, Bugando Medical Centre, Mwanza, Tanzania.
7
AI-REAL Study, Department of Oncology, University of Oxford, Oxford, United Kingdom.
PMID:
37171463
PMCID:
PMC10463187
DOI:
10.1182/bloodadvances.2022009398
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Africa, Eastern / epidemiology
Child
Cohort Studies
Humans
Lymphoma* / diagnosis
Lymphoma* / epidemiology
Lymphoma* / therapy
Time-to-Treatment*
Young Adult